Letco Medical LLC is recalling 173 bottles of Espumil Lipophilic foam base, a pharmaceutical compounding product used in topical medications. The recall was initiated because the product labeling is incorrect or missing necessary information. Approximately 173 bottles were distributed to 44 compounding pharmacies and two distributors primarily located in Alabama and surrounding areas.
The labeling error could lead to improper use or handling of the foam base by compounding pharmacists, potentially resulting in incorrectly formulated medications for patients. No injuries have been reported to date.
You have 2 options:
Recall #: D-0138-2026; Quantity: 173 bottles
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.